CMS Stars

Outcomes Up, Experience Down: Reading the New Cut-Point and Weighting Math

Patient experience measures now carry half the weight they used to, while outcome measures stay heavy. A lower Star Rating may reflect tougher math, not worse care. Here is how to read it and where to spend.

If your overall Star Rating slipped while your actual performance held steady, you are not imagining it, and you are not necessarily doing anything wrong. The scoring math changed underneath you. Two forces, measure weighting and cut points, decide how raw performance turns into stars, and both have moved in ways that punish a strategy built for the old rules. A VP of Quality who reads a lower rating as a care failure will fix the wrong thing. The first job is to read the math correctly.

What actually moved on weighting

Not every measure counts equally. CMS assigns each measure a weight, and the weighted average is what produces your rating. The current structure runs like this. Improvement measures carry the heaviest weight at 5. Outcome and intermediate-outcome measures carry a weight of 3. Process measures carry a weight of 1. And patient experience, complaints, and access measures, which had been elevated to a weight of 4, dropped to a weight of 2 beginning with the 2026 Star Ratings.

That last change is the headline. For several years, patient experience measures were the heaviest non-improvement category in the program, weighted at 4, double the clinical process measures and above the clinical outcomes. Cutting them to 2 cuts their influence on your overall rating in half. It is worth being precise about the source: this weighting change came from earlier rulemaking, the CY2024 rule, and is distinct from the April 2026 CY2027 final rule that removed 11 measures. Two separate regulatory actions are reshaping your rating on overlapping timelines, which is part of why the ground feels unstable.

The net effect of halving experience weight is that clinical outcomes now carry proportionally more of your rating than they have in years. The measures where good medicine and good scores line up are back in the driver’s seat.

A simplified illustration shows the force. Imagine two measures that post the same raw score, one a clinical outcome, one a patient experience measure. Under the old structure, the experience measure at weight 4 pulled harder on your overall rating than the outcome at weight 3. Today, that same experience measure at weight 2 pulls less than the outcome. Nothing about either score changed. The weighted average shifted because the multipliers did. Now scale that across a dozen experience measures and a dozen clinical ones, and you can see how a plan that was strong on experience and middling on outcomes could slide, while a plan with the opposite profile could climb, on raw performance identical to last year. The rebalance rewards a different shape of performance, not a different level of effort.

The CAHPS and clinical split most teams underweight

It helps to name what these categories actually are, because the rebalance is really a shift between two very different kinds of measurement.

Patient experience in the Star Ratings is survey-based. It comes largely from CAHPS, the Consumer Assessment of Healthcare Providers and Systems survey, which asks members directly about getting care, getting appointments, customer service, and how they rate the plan. These are member perceptions, collected by survey, and they move slowly and unpredictably in response to plan effort.

The clinical measures are a different animal. Many of them come from NCQA’s HEDIS measure set, computed from claims and clinical data rather than surveys: controlling blood pressure, managing diabetes, screening for cancer, and the like. These are countable events with a clear numerator and denominator.

So the weighting change is not abstract. CMS moved weight off survey-based CAHPS perception measures and toward countable, clinical HEDIS-style outcomes. If your improvement engine was tuned to chase survey scores, it was tuned for the program that existed through the 2025 ratings, not the one you are in now. The dollars and attention that made sense at weight 4 do not make the same sense at weight 2.

Why CMS rebalanced

The elevation of patient experience to a weight of 4 had pushed the program toward how members felt about their plan and away from the clinical results the plan delivered. That had a logic when it was introduced, but it also meant a plan could ride strong survey scores while clinical outcomes lagged. Reducing experience to a weight of 2 pulls the center of gravity back toward measurable clinical quality. You do not have to agree with the policy to plan around it. The signal is unambiguous: CMS wants the rating to reflect outcomes more and perceptions less, and it has put the weighting behind that preference.

The cut-point machine, for the analytics desk

Weighting decides how much each measure counts. Cut points decide what score earns each star on that measure, and they are where a lot of teams get quietly burned.

Cut points are not fixed. CMS recalculates them every year using a clustering method that groups the actual distribution of plan scores and draws the star thresholds between the clusters. The thresholds are relative. You are not measured against a fixed bar; you are measured against where every other contract landed that year. When the whole field improves on a measure, the bar to earn 4 or 5 stars rises with it. You can post a better raw number than last year and still lose a star on that measure because everyone else improved faster.

A few mechanics matter for modeling. CMS applies Tukey outer-fence outlier deletion before clustering, which strips extreme low outliers out of the distribution so they cannot drag the thresholds down artificially. The practical effect is firmer, often higher, cut points, because the bottom tail that used to soften them is removed first. CMS also applies guardrails that cap how far most cut points can move in a single year, which limits year-to-year whiplash but does not eliminate the upward drift.

The guardrail itself is specific: for most measures, a cut point cannot rise or fall by more than 5 percentage points from one year to the next, with exceptions for new measures and measures that undergo substantive specification changes. That cap smooths the ride, but it works in both directions, and it does nothing to stop a steady, few-points-a-year climb. Over three cycles, a measure can migrate well out of reach while never once tripping the annual limit. A forecast that watches only the single-year guardrail will miss the slow creep that actually costs plans their stars. For a Director of Analytics, the takeaway is blunt: any model that treats this year’s cut points as next year’s is wrong by construction. The target moves, it generally moves up, and it moves based on a distribution you do not control and cannot see until it is published.

Where weighting and cut points collide

The real risk lives at the intersection of the two. A measure becomes dangerous to your rating when it is both heavily weighted and sitting near a cut-point boundary, the position the industry calls a bubble measure. A heavy measure parked just below the 4-star threshold is where a tiny change in raw performance, or a small upward drift in the cut point, swings the most weighted stars. That is where rating movement is won and lost.

This reframes improvement work. The goal is not to lift every measure evenly. It is to find your bubble measures, the ones where weight and proximity to a threshold multiply each other, and move those first. A one-point gain on a heavily weighted measure sitting on a cut-point edge is worth more to your overall rating than a ten-point gain on a lightly weighted measure that is already safely inside a star band. Spreading effort evenly across all measures feels responsible and is, in rating terms, inefficient.

Do not forget the heaviest category

The single heaviest weight in the program belongs to the improvement measures, at 5. These capture whether your scores went up or down year over year, and they are easy to neglect because you cannot work on them directly the way you work on a screening rate. You earn them by improving the measures underneath them, and you can lose them by improving everything except the ones that feed them. High performers face a particular trap: when you are already near the top, there is little room left to improve, and the improvement measures can work against you even as your absolute performance stays excellent. Factor that into where you push, because the measures with the most headroom are often where the heavily weighted improvement credit is easiest to earn.

The strategic read

Put the two changes together and the direction is clear. Outcomes are up in relative importance. Experience is down. The plans that win the next few cycles will move improvement dollars off survey-chasing and onto the clinical and outcome measures that now carry more weight and where performance is more directly within your control.

But do not overcorrect. Patient experience at weight 2 is not weight 0. CAHPS still counts, complaints and disenrollment still feed the rating, and member experience drives retention regardless of its Star weight, which shows up in your revenue whether or not it shows up heavily in your stars. The move is to rebalance toward outcomes, not to abandon experience. A plan that guts its experience investment to chase outcomes will find the floor on those measures sooner than it expects, and a measure at weight 2 can still cost you a star if it falls far enough.

What to do with this

Four moves.

First, re-score yourself under the current weights. Recompute your overall rating with experience at 2 and outcomes at 3, not the structure you modeled last year. Your real position is in that recompute, and it may differ meaningfully from the rating you think you hold.

Second, find your bubble measures. Flag every measure that is both heavily weighted and within striking distance of a cut-point boundary. That list, not the full measure set, is your improvement roadmap. It is where weight and proximity concentrate your rating risk and your opportunity.

Third, reallocate deliberately. Move the marginal improvement dollar from survey-based experience work toward the clinical outcome measures on your bubble list, while keeping experience funded above the level where it would fall through the floor.

Fourth, model the cut points as moving targets. Build your projections on a reasonable estimate of where thresholds drift, not on last year’s published cut points, and treat the guardrails as a ceiling on movement rather than a guarantee of stability. If your forecast assumes static cut points, it is telling you a comfortable story that the clustering method will not honor.

One more, less tactical but just as important: get ahead of the narrative. When your rating moves, someone above you will ask why, and “the weighting changed” sounds like an excuse unless you can show the math. Walk into that conversation with a clean decomposition: this much of the change was the weighting shift, this much was cut-point drift, this much was real performance. A leader who can separate those three for the board turns a defensive moment into a credibility moment. A leader who cannot will spend the next cycle explaining a number instead of moving one.

The honest version

A lower rating can mean worse care. It can also mean the same care measured against a higher bar with a different weighting scheme, and those two diagnoses lead to completely different responses. The plans that confuse them waste a cycle treating a math problem as a care problem, or worse, a care problem as a math problem. Telling them apart requires seeing your performance, the weights, and the cut-point dynamics together, traced to the underlying data, with no hand-waving about why a number moved. That clarity is the entire point of measuring honestly: so that when your rating changes, you know exactly why, and you spend your next dollar on the thing that will actually move it.


HEDIS is a registered trademark of the National Committee for Quality Assurance. CAHPS is a registered trademark of the Agency for Healthcare Research and Quality.

See where your contracts sit against projected cut points.

Apply to our Pilot Cohort

Back to Insights